ALKEM
| Alkem - India
Over the years, Alkem has developed a reputation for its strength in sales and marketing through strong brand building. Alkem has 12 brands listed in the top 300 brands in India, as per IMS. Alkem is rated the No.2 company in the overall antibacterials segment and No.1 in Cephalosporin formulations. Alkem also has significant presence in several other therapy areas such as Gastroenterology, Orthopedics, Oncology, Neuropsychiatry, Cardiovascular and Gynaecology, to name a few. In fact, in several of these segments, Alkem is considered to be a brand leader.
SBUs
Alkem's domestic business is modeled through a strong and established therapy focused Strategic Business Unit's (SBU's)
The following gives the therapy focus of the respective SBU's
Therapy focused SBU's
Main Ulticare Bergen Mediva Pentacare Cytomed
Anti-infective
Gastroenterology
NSAIDs
Nutraceuticals
Anti-infective
Anti-protozoal
Anti-malarial
Nutritionals
Anti-osteoporosis
Anti-bacterial
Pain Management
Cardio Vascular
Anti Diabetic
Anti-Parkison's
Anti-depressants
Anti-psychotics
Anxiolytics
Oncology
HIV Therapy
IVF
Futura Institutional Sales Alkem Health Foods Derma Alkem Pharma
Branded Generics Through trade channels
Public Sector Govt Institution
Natural Nutritional OTC Health Foods
Dermatological Products
Bottom of Pyramid Markets
Whilst the Main Pharma Division, Ulticare and Bergen, are the main revenue generators, the newer specialty divisions, Pentacare (Neuropsychiatry), Mediva (Cardio - Diabeto), Cytomed (Oncology) and dermacare (dermatology) are growing very rapidly and are enhancing their market share in the chronic segment space with a wide range of products in their respective categories.
Select a Therapeutic Group from below to view our product range
Top
What we do
- Formulations
- Alkem - India
- Alkem - International
- Research & Development
- Business development
- Sucralose
Intranet | Sitemap | Administrator | Privacy policy Copyright © Alkem Laboratories, 2008. All rights reserved.